本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Catabasis Pharmaceuticals, Inc.

8.54
0.0000
成交量:- -
成交額:- -
市值:1.10億
市盈率:-0.16
高:8.54
開:8.54
低:8.54
收:8.54
52周最高:47.82
52周最低:6.31
股本:1,282.48萬
流通股本:730.35萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-54.3943
每股收益(LYR):-12.1952
淨資產收益率:-210.26%
總資產收益率:-20.32%
市淨率:2.95
市盈率(LYR):-0.70

資料載入中...

2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/17

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/10

重要事件披露

8-K/A [Amend] - Current report
2021/06/02

重要事件披露

8-K - Current report
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/19

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/16

重要事件披露

8-K - Current report
2021/04/14

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

重要事件披露

8-K - Current report